2-(3-bromoimidazo[1,2-a]pyrimidin-7-yl)propan-2-ol | 461451-31-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并[1，2-a]嘧啶
• 英文名称: 2-(3-bromoimidazo[1,2-a]pyrimidin-7-yl)propan-2-ol
• CAS: 461451-31-0
• 化学式: C₉H₁₀BrN₃O
• 分子量: 256.102
• InChiKey: XLOJYBVXFVKNAO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  50.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(3-bromoimidazo[1,2-a]pyrimidin-7-yl)propan-2-ol 、 5-Fluoro-2-[2-fluoro-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-pyridine 在 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 乙二醇二甲醚 为溶剂， 生成 2-{3-[4-Fluoro-3-(5-fluoro-pyridin-2-yl)-phenyl]-imidazo[1,2-a]pyrimidin-7-yl}-propan-2-ol
  参考文献：
  名称：

  Imidazo[1,2-b][1,2,4]triazines as α2/α3 subtype selective GABAA agonists for the treatment of anxiety

  摘要：

  Imidazo[1,2-a]pyrimidines and imidazo[1,2-b][1,2,4]triazines are ligands for the benzodiazepine binding site of GABA(A) receptors that are functionally selective for the alpha 2/alpha 3 subtypes over the alpha 1 subtype. SAR studies to optimise this functional selectivity, pharmacokinetic and behavioural data are described. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.12.044
• 作为产物：
  描述：

  3-羟基-3-甲基-2-丁酮 在 4-二甲氨基吡啶 、 乙醇 、 三氟化硼乙醚 、 溴 、 sodium methylate 、 sodium acetate 、 三乙胺 、 potassium bromide 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 30.45h， 生成 2-(3-bromoimidazo[1,2-a]pyrimidin-7-yl)propan-2-ol
  参考文献：
  名称：

  Efficient Synthesis of a GABA_A α_2,3-Selective Allosteric Modulator via a Sequential Pd-Catalyzed Cross-Coupling Approach

  摘要：

  A practical synthesis of 2- [3-(4-fluoro-3-pyridin-3-yl-phenyl)-imidazo [1,2-a] pyrimidin-7-yl] -propan-2-ol (1), an oral GABA(A) alpha(2/3)-selective agonist, is described. The five-step process, which afforded 1 in 40% overall yield, included imidazopyrimidine 2 and pyridine boronic acid 4 as key fragments. The synthesis is highlighted by consecutive Pd-catalyzed coupling steps to assemble the final free base 1 in high yield and regioselectivity. A novel method for Pd removal in the final step is also described.

  DOI：

  10.1021/jo050741o

文献信息

• Imidazo-pyrimidine derivatives as ligands for gaba receptors
  申请人：——

  公开号：US20020193385A1

  公开（公告）日：2002-12-19

  A class of 3-phenylimidazo[1,2-&agr;]pyrimidine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, and further substituted on the phenyl ring by alkyl, trifluoromethyl, alkoxy or one or two halogen atoms, especially fluoro, are selective ligands for GABA A receptors, in particular having good affinity for the &agr;2 and/or &agr;3 and/or &agr;5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类3-苯基咪唑[1,2-&agr;]嘧啶衍生物，苯环的间位被取代，取代基可以是直接连接或通过氧原子或-NH-键桥接的取代芳基或杂环芳基，苯环上进一步被取代为烷基，三氟甲基，烷氧基或一个或两个卤素原子，特别是氟，是GABAA受体的选择性配体，特别是对其中的&agr;2和/或&agr;3和/或&agr;5亚基具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑，惊厥和认知障碍具有益处。
• 3-Phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
  申请人：——

  公开号：US20030176449A1

  公开（公告）日：2003-09-18

  A class of 3-phenylimidazo(1,2-&agr;) pyrimidine derivatives (of Formula I, or salt or prodrug thereof: I) wherein Y represents a chemical bond, an oxygen atom, or a —NH— linkage; Z represents an optionally substituted aryl or heteroaryl group; R 1 represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano trifluoromethyl, nitro, —OR a , —SR a , —SOR a , —SO 2 R a , —SO 2 NR a R b , —NR a R b , —NR a COR b , —NR a CO 2 R b , —COR a , CO 2 R a , —CONR a R b or —CR a ═NOR b ; and R a and R b independently represent hydrogen, hydrocarbon or a heterocyclic group.), substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, are selective ligands for GABA A receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders. 1

  一类3-苯基咪唑并(1,2-a)嘧啶衍生物（公式I中的盐或前药：I），其中Y代表化学键，氧原子或-NH-键；Z代表可选取代的芳基或杂芳基基团；R1代表氢，碳氢化合物，杂环基团，卤素，氰基，三氟甲基，硝基，-ORa，-SRa，-SORa，-SO2Ra，-SO2NRaRb，-NRaRb，-NRaCORb，-NRaCO2Rb，-CORa，CO2Ra，-CONRaRb或-CRa═NORb；而Ra和Rb分别独立地代表氢，碳氢化合物或杂环基团，取代苯环的meta位，由氧原子或-NH-键直接连接或桥接的可选取代的芳基或杂芳基基团，是GABAA受体的选择性配体，特别是对其中的a2和/或a3和/或a5亚单位具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑，惊厥和认知障碍具有益处。
• 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
  申请人：Merck Sharp & Dohme Ltd.

  公开号：US06642229B2

  公开（公告）日：2003-11-04

  A class of 3-phenylimidazo(1,2-a)pyrimidine derivatives (of Formula I, or salt or prodrug thereof: I) wherein Y represents a chemical bond, an oxygen atom, or a —NH— linkage; Z represents an optionally substituted aryl or heteroaryl group; R1 represents hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano trifluoromethyl, nitro, —ORa, —SRa, —SORa, —SO2Ra, —SO2NRaRb, —NRaRb, —NRaCORb, —NRaCO2Rb, —CORa, CO2Ra, —CONRaRb or —CRa═NORb; and Ra and Rb independently represent hydrogen, hydrocarbon or a heterocyclic group.), substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, are selective ligands for GABAA receptors, in particular having good affinity for the a2 and/or a3 and/or a5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类3-苯基咪唑并[1,2-a]嘧啶衍生物（化学式I，或其盐或前药：I），其中Y代表化学键，氧原子或—NH—连接；Z代表可选取代的芳基或杂芳基基团；R1代表氢、碳氢化合物、杂环基团、卤素、氰、三氟甲基、硝基、—ORa、—SRa、—SORa、—SO2Ra、—SO2NRaRb、—NRaRb、—NRaCORb、—NRaCO2Rb、—CORa、CO2Ra、—CONRaRb或—CRa═NORb；而Ra和Rb分别独立地代表氢、碳氢化合物或杂环基团。这些衍生物在苯环的间位上取代了可选取代的芳基或杂芳基基团，该基团直接连接或通过氧原子或—NH—连接桥接，是GABAA受体的选择性配体，特别是对a2和/或a3和/或a5亚单位具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑、惊厥和认知障碍，具有益处。
• Imidazo-pyrimidine derivatives as ligands for GABA receptors
  申请人：Merck Sharp & Dohme Ltd.

  公开号：US07030128B2

  公开（公告）日：2006-04-18

  A class of imidazo[1,2-α]pyrimidine derivatives, substituted at the 3-position by an optionally substituted five-membered or six-membered heteroaromatic ring, are selective ligands for GABAA receptors, in particular having good affinity for the α2 and/or α3 and/or α5 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.

  一类在3位取代了一个选择性取代的五元或六元杂环芳香环的咪唑[1,2-α]嘧啶衍生物是GABAA受体的选择性配体，尤其对其中的α2和/或α3和/或α5亚基具有良好的亲和力，因此对于治疗和/或预防中枢神经系统的不良症状，包括焦虑、抽搐和认知障碍具有益处。
• Imidazo[1,2<i>-a</i>]pyrimidines as Functionally Selective and Orally Bioavailable GABA_Aα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders
  作者：Simon C. Goodacre、Leslie J. Street、David J. Hallett、James M. Crawforth、Sarah Kelly、Andrew P. Owens、Wesley P. Blackaby、Richard T. Lewis、Joanna Stanley、Alison J. Smith、Pushpinder Ferris、Bindi Sohal、Susan M. Cook、Andrew Pike、Nicola Brown、Keith A. Wafford、George Marshall、José L. Castro、John R. Atack

  DOI：10.1021/jm051065l

  日期：2006.1.1

  A series of high-affinity GABA(A) agonists with good oral bioavailability in rat and dog and functional selectivity for or the GABA(A)alpha 2 and -alpha 3 subtypes is reported. The 7-trifluoroinethylimidazopyrimidine 14g and the 7-propan-2-olimidazopyrimidine 14k are anxiolytic in both conditioned and unconditioned animal models of anxiety with minimal sedation observed at full BZ binding site occupancy.